TREM2 and metabolic dysfunction-associated steatohepatitis: More recently, using single-cell RNA sequencing technology, multiple studies in lipid-mediated disorders including NASH and atherosclerosis demonstrate the occurrence of a specialized type of macrophages characterized by high expression of the triggering receptor expressed on myeloid cells 2 (Trem2).